FERMENTA BIOTECH LTD. (FERMENTA) financials

FERMENTA BIOTECH LTD. (FERMENTA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1951, Fermenta BiotechLtd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products[1]

Market Cap: ₹1,369Cr.
Current Price: ₹465
Stock P/E: 23.7
ROE: 13.8%
ROCE: 18.3%
Book Value: ₹144
Dividend Yield: 0.81%
52W High / Low: ₹583/249

In Jun 2026, FERMENTA BIOTECH LTD. (FERMENTA) reported sales ₹112 Cr and net profit ₹15 Cr.

Annual TTM: sales ₹443 Cr, net profit ₹63 Cr.

Shareholding: Promoters 60.12% (Sep 2026), FIIs 1.05% (Sep 2026), DIIs 0.00% (Sep 2026), Public 36.43% (Sep 2026), Others 2.39% (Sep 2026).

FERMENTA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	90	146	122	119	107	114	110	112
Expenses	74	96	89	96	84	91	88	89
Operating Profit	15	50	33	23	23	23	22	23
OPM %	17%	34%	27%	19%	21%	21%	20%	21%
Other Income	3	2	4	9	6	1	15	5
Interest	4	4	3	3	3	3	3	3
Depreciation	6	6	6	6	5	5	5	5
Profit before tax	9	42	28	23	21	17	29	20
Tax %	8%	18%	-5%	29%	29%	29%	26%	26%
Net Profit	8	35	29	16	15	12	22	15
EPS in Rs	2.77	11.89	9.96	5.51	5.00	4.00	7.33	5.09
Raw PDF	—	—	—	—	—	—	—	—

FERMENTA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	299	371	387	328	307	429	448	443
Expenses	229	276	310	288	269	323	356	352
Operating Profit	70	95	77	39	38	106	92	91
OPM %	24%	26%	20%	12%	12%	25%	20%	21%
Other Income	12	6	8	-51	-1	7	31	27
Interest	20	19	18	21	17	15	12	11
Depreciation	15	19	24	24	24	23	21	21
Profit before tax	48	63	43	-58	-5	74	89	87
Tax %	-34%	18%	29%	-2%	307%	9%	28%	—
Net Profit	64	52	30	-57	-19	68	64	63
EPS in Rs	21.63	17.66	10.27	-19.37	-6.37	22.98	21.84	21.42
Dividend Payout %	23%	14%	12%	-6%	-19%	11%	17%	—

FERMENTA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	5	14	14	14	14	14	15	14
Reserves	245	298	356	382	322	300	365	408
Borrowings	209	226	234	241	219	139	115	113
Other Liabilities	93	71	78	76	108	112	128	116
Total Liabilities	551	610	683	713	664	565	622	652
Fixed Assets	177	197	250	287	257	267	226	220
CWIP	22	71	57	35	45	2	16	13
Investments	8	1	13	13	15	4	4	12
Other Assets	344	341	363	378	347	293	377	408
Total Assets	551	610	683	713	664	565	622	652

FERMENTA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	91	30	63	50	124	105	34	83
Cash from Investing Activity	-97	-39	-44	-32	-63	-15	0	-46
Cash from Financing Activity	12	-48	-1	-22	-41	-91	-51	-42
Net Cash Flow	6	-57	18	-4	19	-1	-17	-6
Free Cash Flow	55	-34	8	13	83	86	31	52
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	83%	62%	81%	78%	304%	276%	35%	108%

FERMENTA shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	62.06%	64.08%	64.08%	64.08%	64.08%	64.08%	64.08%	60.12%
FIIs	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.13%	1.05%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.00%
Public	36.98%	35.00%	35.00%	34.75%	33.99%	33.32%	33.19%	36.43%
Others	0.94%	0.89%	0.89%	1.14%	1.90%	2.58%	2.55%	2.39%
No. of Shareholders	12,922	12,930	12,845	13,760	14,139	13,661	14,131	16,084

FERMENTA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	59	94	95	111	75	92	102	112
Inventory Days	347	501	392	328	317	272	235	311
Days Payable	172	208	135	115	150	184	160	151
Cash Conversion Cycle	234	387	352	324	242	180	177	272
Working Capital Days	42	225	73	92	-19	25	51	122
ROCE %	45%	13%	14%	10%	4%	4%	20%	18%

FERMENTAUpdated 22 Oct 2026, 3:37

Fermenta Biotech Ltd.

FERMENTAUpdated 22 Oct 2026, 3:37

Market Cap

₹1,369Cr.

Current Price

₹465

High / Low

₹583/249

Stock P/E

23.7

ROE13.8%

ROCE18.3%

Book Value₹144

Face Value₹5.00

Dividend Yield0.81%

About

Incorporated in 1951, Fermenta BiotechLtd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	77	5	64	2	6	5	0	5	1.63
Sep 2023	51	4	63	-7	6	-28	0	-28	-9.51
Dec 2023	89	5	63	3	6	18	34	12	3.98
Mar 2024	90	3	81	2	6	1	994	-7	-2.46
Jun 2024	73	3	71	3	6	-5	0	-5	-1.65
Sep 2024	90	4	74	3	6	9	8	8	2.77
Dec 2024	146	4	96	2	6	42	18	35	11.89
Mar 2025	122	3	89	4	6	28	-5	29	9.96
Jun 2025	119	3	96	9	6	23	29	16	5.51
Sep 2025	107	3	84	6	5	21	29	15	5
Dec 2025	114	3	91	1	5	17	29	12	4
Mar 2026	110	3	88	15	5	29	26	22	7.33
Jun 2026	112	3	89	5	5	20	26	15	5.09

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	14	0	11	0	2	1	30	1	0.26
Mar 2016	6	2	12	1	2	-9	-1	-9	-3.31
Mar 2017	6	6	14	0	3	-18	2	-18	-6.63
Mar 2018	13	11	22	0	4	-23	3	-24	-8.75
Mar 2019	403	21	255	6	12	121	9	110	40.13
Mar 2020	299	20	229	12	15	48	-34	64	21.63
Mar 2021	371	19	276	6	19	63	18	52	17.66
Mar 2022	387	18	310	8	24	43	29	30	10.27
Mar 2023	328	21	288	-51	24	-58	-2	-57	-19.37
Mar 2024	307	17	269	-1	24	-5	307	-19	-6.37
Mar 2025	429	15	323	7	23	74	9	68	22.98
Mar 2026	448	12	356	31	21	89	28	64	21.84
TTM	443	11	352	27	21	87	—	63	21.42

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	60.12%
FIIs	1.05%
Public	36.43%
Others	2.39%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public	Others
Dec 2023	62.06%	0%	0%	—	36.05%	1.89%
Mar 2024	62.06%	0%	0%	—	36.05%	1.89%
Jun 2024	62.06%	0%	0%	—	36.11%	1.82%
Sep 2024	62.06%	0.05%	0%	—	36.41%	1.47%
Dec 2024	62.06%	0.02%	0%	—	36.98%	0.94%
Mar 2025	64.08%	0.02%	0%	—	35%	0.89%
Jun 2025	64.08%	0.02%	0%	—	35%	0.89%
Sep 2025	64.08%	0.02%	0%	—	34.75%	1.14%
Dec 2025	64.08%	0.02%	0%	—	33.99%	1.9%
Mar 2026	64.08%	0.02%	0%	—	33.32%	2.58%
Jun 2026	64.08%	0.13%	0.04%	—	33.19%	2.55%
Sep 2026	60.12%	1.05%	0%	—	36.43%	2.39%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	2	90	35	15	143	7	63	40	33	143
Mar 2016	2	80	52	15	149	93	1	41	15	149
Mar 2017	2	87	44	12	146	94	1	40	12	146
Mar 2018	2	62	143	15	223	96	0	118	9	223
Mar 2019	5	245	209	93	551	177	22	8	344	551
Mar 2020	14	298	226	71	610	197	71	1	341	610
Mar 2021	14	356	234	78	683	250	57	13	363	683
Mar 2022	14	382	241	76	713	287	35	13	378	713
Mar 2023	14	322	219	108	664	257	45	15	347	664
Mar 2024	14	300	139	112	565	267	2	4	293	565
Mar 2025	15	365	115	128	622	226	16	4	377	622
Mar 2026	14	408	113	116	652	220	13	12	408	652

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	0	-11	9	-2
Mar 2016	-5	-8	14	1
Mar 2017	-9	20	-13	-2
Mar 2018	1	-89	88	1
Mar 2019	91	-97	12	6
Mar 2020	30	-39	-48	-57
Mar 2021	63	-44	-1	18
Mar 2022	50	-32	-22	-4
Mar 2023	124	-63	-41	19
Mar 2024	105	-15	-91	-1
Mar 2025	34	0	-51	-17
Mar 2026	83	-46	-42	-6

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	5	2	26	8	59	94	95	111	75	92	102	112
Inventory Days	—	—	—	—	347	501	392	328	317	272	235	311
Days Payable	—	—	—	—	172	208	135	115	150	184	160	151
Cash Conversion Cycle	5	2	26	8	234	387	352	324	242	180	177	272
Working Capital Days	-923	-2,525	-769	-456	42	225	73	92	-19	25	51	122
ROCE %	1%	-5%	-9%	-7%	45%	13%	14%	10%	4%	4%	20%	18%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of FERMENTA BIOTECH LTD. (FERMENTA)?

The reported market capitalisation for FERMENTA BIOTECH LTD. (FERMENTA) is ₹1,369Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of FERMENTA?

The current price shown for FERMENTA BIOTECH LTD. (FERMENTA) on Fincrux is ₹465 with a 52-week high/low of ₹583/249.

What is the P/E ratio of FERMENTA BIOTECH LTD. (FERMENTA)?

The stock P/E for FERMENTA BIOTECH LTD. (FERMENTA) is 23.7 on Fincrux, with ROE at 13.8% and ROCE at 18.3%.

What were FERMENTA latest quarterly results?

For Jun 2026, FERMENTA BIOTECH LTD. (FERMENTA) reported sales ₹112 Cr and net profit ₹15 Cr (figures in ₹ crore unless noted).

What are FERMENTA annual sales and net profit?

For TTM, FERMENTA BIOTECH LTD. (FERMENTA) shows sales of ₹443 Cr and net profit of ₹63 Cr on the Fincrux profit & loss statement.

Who owns FERMENTA BIOTECH LTD. (FERMENTA)?

Latest shareholding for FERMENTA BIOTECH LTD. (FERMENTA) on Fincrux: Promoters 60.12% (Sep 2026), FIIs 1.05% (Sep 2026), DIIs 0.00% (Sep 2026), Public 36.43% (Sep 2026), Others 2.39% (Sep 2026).

Where can I find FERMENTA BIOTECH LTD. (FERMENTA) financials?

FERMENTA BIOTECH LTD. (FERMENTA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show FERMENTA balance sheet and cash flow?

Yes. The FERMENTA BIOTECH LTD. (FERMENTA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 22 October 2026 at 3:37